MARKETS
Markets

Xtant Medical Enters Exclusive Partnership With Henry Schein's Biohorizons To Distribute The Company's Allogeneic Growth Factor Technology Under The Prolifica Private Brand

Aug 27, 2026 · 08:10 AM ET· updated 1h ago

The agreement establishes BioHorizons as the exclusive distributor of Xtant's allogeneic growth factor technology into the dental and oral-maxillofacial procedure markets in the United States and Canada, expanding

Share
Why It Matters

Xtant Medical found a big partner (Henry Schein's BioHorizons) to help sell its special dental products across the US and Canada. This is like finding a really strong teammate to help your business reach more customers.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.